Under Armour, Inc. Class A (UAA)

11.01
0.03 0.27
NYSE
Prev Close 10.98
Open 11.23
Day Low/High 11.18 / 11.23
52 Wk Low/High 7.15 / 21.96
Volume 104.90K
Exchange NYSE
Shares Outstanding 454.49B
Market Cap 4.87B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Under Armour downgraded at Nomura

Under Armour upgraded at Morgan Stanley

Stephen Curry Has a Humorous Take on Under Armour CEO's Praise of Trump

Stephen Curry Has a Humorous Take on Under Armour CEO's Praise of Trump

Praise for President Trump's controversial immigration ban has riled up people across the country, including NBA player Steph Curry.

Ulta and Nvidia: Know When to Fold 'Em

Ulta and Nvidia: Know When to Fold 'Em

Use knowledge of what happened to those who didn't sell out of Under Armour and Chipotle.

Say It Ain't So, Mr. Macy!

Shares of Macy's are higher (up 4%) in pre-market trading on a New York Post report that the company may be put up for sale.  On Monday I made a package of Macy's, JC Penney and VanEck Vectors Retail ETF my "Trade of the Week": Trade of the Week -- ...

Ulta and Nvidia: Know When to Fold 'Em

Ulta and Nvidia: Know When to Fold 'Em

Use knowledge of what happened to those who didn't sell out of Under Armour and Chipotle.

Sis Boom Blah

I always am in wonderment how the business media highlights the positives (stocks/sectors that are rising TODAY) and de-emphasizes the negatives (often the stocks/sectors that were rising in the recent past but are declining TODAY).   Their memories...

What Do Under Armour CEO Kevin Plank's Stock Sales Mean?

What Do Under Armour CEO Kevin Plank's Stock Sales Mean?

Plank last sold 1.05 million shares of Under Armour in a series of transactions from April 21 to April 29 of 2016.

Under Armour downgraded at FBR

Cramer: Trump's Carrot-Stick Approach Doesn't Make Pharma Any More Attractive

Cramer: Trump's Carrot-Stick Approach Doesn't Make Pharma Any More Attractive

Two industries should largely be avoided under this administration: pharma and retail.

Under Armour Could Be a Buy on This Weakness

Under Armour Could Be a Buy on This Weakness

I believe today's setbacks are short term, and UAA can right the ship in time.

Change in Strategy as Under Armour Underperforms

Under Armour's big earnings miss and CFO resignation likely will weigh heavily on retail stocks today. Yesterday I made a retail package of JC Penney , VanEck Vectors Retail ETF and Macy's my "Trade of the Week."  That was a mistake in timing, and t...

Markets Await Apple Earnings on Tuesday

Markets Await Apple Earnings on Tuesday

Apple reports fiscal 2017 first-quarter earnings on Tuesday after the markets close.

Growth Seeker Portfolio: Earnings Start to Give Clearer Picture

Growth Seeker Portfolio: Earnings Start to Give Clearer Picture

The portfolio had several outperformers during the first week of the new president's term.

Small Biotechs Dominate List of Stocks That Could Torpedo Your Portfolio

Small Biotechs Dominate List of Stocks That Could Torpedo Your Portfolio

Very few of these companies every get the drug to market.

Is Under Armour Awakening From Its Slumber?

Is Under Armour Awakening From Its Slumber?

We're initiating a position in UAA today for a trade.

Growth Seeker Portfolio: Living Up to Our Name

Growth Seeker Portfolio: Living Up to Our Name

As we enter a new year, we'll be seeking growth in 2017 and beyond, much like we have with our existing positions.

Sniffing Around for Dogs of the Dow

Sniffing Around for Dogs of the Dow

Nike is down 19.6% so far this year vs. a 13.8% gain for the Dow Jones Industrial Average.